INCYTE CORPORATION Defined Benefit Plan, Net Periodic Benefit Cost (Credit)
INCYTE CORPORATION (INCY) reported Defined Benefit Plan, Net Periodic Benefit Cost (Credit) of $3.06 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost · last filed 2026-04-28
- INCYTE CORPORATION defined benefit plan, net periodic benefit cost (credit) for the quarter ending 2026-03-31 was $3.06M, a 4.90% increase year-over-year.
- INCYTE CORPORATION defined benefit plan, net periodic benefit cost (credit) for the quarter ending 2025-12-31 was $3.31M, a 6.92% increase year-over-year.
- INCYTE CORPORATION defined benefit plan, net periodic benefit cost (credit) for the quarter ending 2025-09-30 was $3.27M, a 81.94% increase year-over-year.
- INCYTE CORPORATION defined benefit plan, net periodic benefit cost (credit) for the quarter ending 2025-06-30 was $3.20M, a 53.63% increase year-over-year.
- INCYTE CORPORATION defined benefit plan, net periodic benefit cost (credit) for fiscal 2025 was $12.70M, a 43.63% increase from fiscal 2024.
- INCYTE CORPORATION defined benefit plan, net periodic benefit cost (credit) for fiscal 2024 was $8.84M, a 74.24% increase from fiscal 2023.
- INCYTE CORPORATION defined benefit plan, net periodic benefit cost (credit) for fiscal 2023 was $5.07M, a 28.04% decline from fiscal 2022.
- INCYTE CORPORATION defined benefit plan, net periodic benefit cost (credit) for fiscal 2022 was $7.05M, a 24.83% decline from fiscal 2021.
| Period end | Defined Benefit Plan, Net Periodic Benefit Cost (Credit) 3 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit) 6 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit) 9 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit) 12 month |
|---|---|---|---|---|
| 2026-03-31 | $3.06M 10-Q · filed 2026-04-28 | $6.37M derived: sum of 2 quarters · filed 2026-04-28 | $9.64M derived: sum of 3 quarters · filed 2026-04-28 | $12.84M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $6.58M derived: sum of 2 quarters · filed 2026-02-10 | $9.78M derived: sum of 3 quarters · filed 2026-02-10 | $12.70M 10-K · filed 2026-02-10 |
| 2025-09-30 | $3.27M 10-Q · filed 2025-10-28 | $6.47M derived: sum of 2 quarters · filed 2025-10-28 | $9.39M 10-Q · filed 2025-10-28 | $12.48M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $3.20M 10-Q · filed 2025-07-29 | $6.12M 10-Q · filed 2025-07-29 | $9.21M derived: sum of 3 quarters · filed 2026-04-28 | $11.01M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $2.92M 10-Q · filed 2026-04-28 | $6.01M derived: sum of 2 quarters · filed 2026-04-28 | $7.81M derived: sum of 3 quarters · filed 2026-04-28 | $9.89M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $4.89M derived: sum of 2 quarters · filed 2026-02-10 | $6.97M derived: sum of 3 quarters · filed 2026-02-10 | $8.84M 10-K · filed 2026-02-10 |
| 2024-09-30 | $1.80M 10-Q · filed 2025-10-28 | $3.88M derived: sum of 2 quarters · filed 2025-10-28 | $5.75M 10-Q · filed 2025-10-28 | $7.02M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $2.08M 10-Q · filed 2025-07-29 | $3.95M 10-Q · filed 2025-07-29 | $5.22M derived: sum of 3 quarters · filed 2026-02-10 | $6.44M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $1.87M 10-Q · filed 2025-04-29 | $3.14M derived: sum of 2 quarters · filed 2026-02-10 | $4.36M derived: sum of 3 quarters · filed 2026-02-10 | $5.58M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $2.49M derived: sum of 2 quarters · filed 2026-02-10 | $3.72M derived: sum of 3 quarters · filed 2026-02-10 | $5.07M 10-K · filed 2026-02-10 |
| 2023-09-30 | $1.22M 10-Q · filed 2024-10-29 | $2.44M derived: sum of 2 quarters · filed 2024-10-29 | $3.80M 10-Q · filed 2024-10-29 | $5.60M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $1.23M 10-Q · filed 2024-07-30 | $2.58M 10-Q · filed 2024-07-30 | $4.38M derived: sum of 3 quarters · filed 2025-02-10 | $6.09M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $1.36M 10-Q · filed 2024-04-30 | $3.15M derived: sum of 2 quarters · filed 2025-02-10 | $4.87M derived: sum of 3 quarters · filed 2025-02-10 | $6.61M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $3.51M derived: sum of 2 quarters · filed 2025-02-10 | $5.25M derived: sum of 3 quarters · filed 2025-02-10 | $7.05M 10-K · filed 2025-02-10 |
| 2022-09-30 | $1.71M 10-Q · filed 2023-10-31 | $3.46M derived: sum of 2 quarters · filed 2023-10-31 | $5.25M 10-Q · filed 2023-10-31 | $7.66M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $1.75M 10-Q · filed 2023-08-01 | $3.54M 10-Q · filed 2023-08-01 | $5.95M derived: sum of 3 quarters · filed 2024-02-13 | $8.27M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $1.80M 10-Q · filed 2023-05-02 | $4.20M derived: sum of 2 quarters · filed 2024-02-13 | $6.53M derived: sum of 3 quarters · filed 2024-02-13 | $8.87M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $4.73M derived: sum of 2 quarters · filed 2024-02-13 | $7.08M derived: sum of 3 quarters · filed 2024-02-13 | $9.38M 10-K · filed 2024-02-13 |
| 2021-09-30 | $2.33M 10-Q · filed 2022-11-01 | $4.67M derived: sum of 2 quarters · filed 2022-11-01 | $6.98M 10-Q · filed 2022-11-01 | $8.81M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $2.35M 10-Q · filed 2022-08-02 | $4.65M 10-Q · filed 2022-08-02 | $6.48M derived: sum of 3 quarters · filed 2023-02-07 | $8.24M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $2.30M 10-Q · filed 2022-05-03 | $4.13M derived: sum of 2 quarters · filed 2023-02-07 | $5.89M derived: sum of 3 quarters · filed 2023-02-07 | $7.61M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $3.59M derived: sum of 2 quarters · filed 2023-02-07 | $5.30M derived: sum of 3 quarters · filed 2023-02-07 | $7.00M 10-K · filed 2023-02-07 |
| 2020-09-30 | $1.76M 10-Q · filed 2021-11-02 | $3.47M derived: sum of 2 quarters · filed 2021-11-02 | $5.17M 10-Q · filed 2021-11-02 | $6.69M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $1.71M 10-Q · filed 2021-08-03 | $3.41M 10-Q · filed 2021-08-03 | $4.93M derived: sum of 3 quarters · filed 2022-02-08 | $6.35M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $1.69M 10-Q · filed 2021-05-04 | $3.22M derived: sum of 2 quarters · filed 2022-02-08 | $4.64M derived: sum of 3 quarters · filed 2022-02-08 | $6.06M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $2.94M derived: sum of 2 quarters · filed 2022-02-08 | $4.36M derived: sum of 3 quarters · filed 2022-02-08 | $5.76M 10-K · filed 2022-02-08 |
| 2019-09-30 | $1.42M 10-Q · filed 2020-11-05 | $2.84M derived: sum of 2 quarters · filed 2020-11-05 | $4.23M 10-Q · filed 2020-11-05 | $5.66M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $1.42M 10-Q · filed 2020-08-04 | $2.82M 10-Q · filed 2020-08-04 | $4.25M derived: sum of 3 quarters · filed 2021-02-09 | $5.42M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $1.40M 10-Q · filed 2020-05-05 | $2.83M derived: sum of 2 quarters · filed 2021-02-09 | $4.00M derived: sum of 3 quarters · filed 2021-02-09 | $5.16M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $2.60M derived: sum of 2 quarters · filed 2021-02-09 | $3.77M derived: sum of 3 quarters · filed 2021-02-09 | $4.98M 10-K · filed 2021-02-09 |
| 2018-09-30 | $1.17M 10-Q · filed 2019-10-29 | $2.34M derived: sum of 2 quarters · filed 2019-10-29 | $3.55M 10-Q · filed 2019-10-29 | $4.50M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $1.16M 10-Q · filed 2019-07-30 | $2.38M 10-Q · filed 2019-07-30 | $3.32M derived: sum of 3 quarters · filed 2020-02-13 | $4.14M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $1.21M 10-Q · filed 2019-04-30 | $2.16M derived: sum of 2 quarters · filed 2020-02-13 | $2.98M derived: sum of 3 quarters · filed 2020-02-13 | $3.72M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $949.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $1.77M derived: sum of 2 quarters · filed 2020-02-13 | $2.51M derived: sum of 3 quarters · filed 2020-02-13 | $3.18M 10-K · filed 2020-02-13 |
| 2017-09-30 | $820.00K 10-Q · filed 2018-10-30 | $1.56M derived: sum of 2 quarters · filed 2018-10-30 | $2.23M 10-Q · filed 2018-10-30 | $2.96M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $741.00K 10-Q · filed 2018-07-31 | $1.41M 10-Q · filed 2018-07-31 | $2.15M derived: sum of 3 quarters · filed 2019-02-14 | $2.52M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $673.00K 10-Q · filed 2018-05-01 | $1.40M derived: sum of 2 quarters · filed 2019-02-14 | $1.77M derived: sum of 3 quarters · filed 2019-02-14 | $1.92M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $731.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $1.10M derived: sum of 2 quarters · filed 2019-02-14 | $1.24M derived: sum of 3 quarters · filed 2019-02-14 | $1.24M 10-K · filed 2019-02-14 |
| 2016-09-30 | $371.00K 10-Q · filed 2017-10-31 | $511.00K derived: sum of 2 quarters · filed 2017-10-31 | $511.00K 10-Q · filed 2017-10-31 | |
| 2016-06-30 | $140.00K 10-Q · filed 2017-08-01 | $140.00K 10-Q · filed 2017-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |